Gliptus Plus tablets

Gliptus Plus is a pharmaceutical product primarily used in the management of type 2 diabetes. It is a combination medication containing Vildagliptin and Metformin hydrochloride, designed to help control blood sugar levels in adult patients. The product is manufactured in Egypt by EVA Pharma, one of the region's leading pharmaceutical companies.

EVA Pharma has its roots in Egypt, starting from the Delta State Company for Medicines which was established in 1935. Over the decades, it has evolved into a major multinational healthcare organization. The brand remains under the ownership of EVA Pharma, which continues to operate as a privately held company headquartered in Cairo, Egypt, serving markets across the Middle East, Africa, and beyond.